Crossmark

Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer

Crossref DOI link: https://doi.org/10.1186/S13058-018-1095-7

Published: 2019-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Nokin, Marie-Julie

Bellier, Justine

Durieux, Florence

Peulen, Olivier

Rademaker, Gilles

Gabriel, Maude

Monseur, Christine

Charloteaux, Benoit

Verbeke, Lieven

van Laere, Steven

Roncarati, Patrick

Herfs, Michael

Lambert, Charles

Scheijen, Jean

Schalkwijk, Casper

Colige, Alain

Caers, Jo

Delvenne, Philippe

Turtoi, Andrei

Castronovo, Vincent

Bellahcène, Akeila http://orcid.org/0000-0001-9154-7631
Funding

Funding for this research was provided by:

Fonds De La Recherche Scientifique - FNRS

Université de Liège
License Information

Text and Data Mining valid from 2019-01-23
More Information

Article History

Received: 25 June 2018

Accepted: 27 December 2018

First Online: 23 January 2019

Ethics approval

: All animal experimental procedures were performed according to the Federation of European Laboratory Animal Sciences Associations (FELASA) and were reviewed and approved by the Institutional Animal Care and Ethics Committee of the University of Liege (Belgium). The reference number is 17-1917.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.